Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Brimonidine Reduces IPL-induced Erythema Without Affecting Efficacy: a Randomized Controlled Trial in Patients With Facial Telangiectasias

NCT02761174 is registered in ClinicalTrials.gov with Merete Haedersdal as lead sponsor.

NCT NCT02761174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02761174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Brimonidine Reduces IPL-induced Erythema Without Affecting Efficacy: a Randomized Controlled Trial in Patients With Facial Telangiectasias
Lead sponsor
Merete Haedersdal
Phase
Phase 4
Overall status
Completed
Start date
March 13, 2016
Completion date
January 13, 2017
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

telangiectasias